论文信息 - A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L). - 字舞流文

A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L).

F. Meric-Bernstam | P. LoRusso | G. Schwartz | W. Tap | M. Gounder | D. Hyman | D. Hong | R. Carvajal | N. Somaiah | T. Bauer | Shuquan Chen | Prasanna Kumar | J. Kochan | A. Weise | O. Zernovak | J. Mendell-Harary | J. Doyle | A. Beck